Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07628595 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07628595
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-12-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.